NDC 0409-5093

TAZICEF

Ceftazidime

TAZICEF is a Intravenous Injection, Powder, For Solution in the Human Prescription Drug category. It is labeled and distributed by Hospira, Inc.. The primary component is Ceftazidime.

Product ID0409-5093_0b84920a-5767-4665-bdfc-50bbfcea6d97
NDC0409-5093
Product TypeHuman Prescription Drug
Proprietary NameTAZICEF
Generic NameCeftazidime
Dosage FormInjection, Powder, For Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2006-04-05
Marketing CategoryANDA / ANDA
Application NumberANDA064032
Labeler NameHospira, Inc.
Substance NameCEFTAZIDIME
Active Ingredient Strength2 g/1
Pharm ClassesCephalosporin Antibacterial [EPC],Cephalosporins [CS]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 0409-5093-11

10 VIAL, PATENT DELIVERY SYSTEM in 1 TRAY (0409-5093-11) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, PATENT DELIVERY SYSTEM (0409-5093-14)
Marketing Start Date2006-04-05
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0409-5093-11 [00409509311]

TAZICEF INJECTION, POWDER, FOR SOLUTION
Marketing CategoryANDA
Application NumberANDA064032
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2006-04-05

NDC 0409-5093-51 [00409509351]

TAZICEF INJECTION, POWDER, FOR SOLUTION
Marketing CategoryANDA
Application NumberANDA064032
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2012-03-06
Marketing End Date2014-10-30

NDC 0409-5093-14 [00409509314]

TAZICEF INJECTION, POWDER, FOR SOLUTION
Marketing CategoryANDA
Application NumberANDA064032
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2018-11-13

Drug Details

Active Ingredients

IngredientStrength
CEFTAZIDIME2 g/1

OpenFDA Data

SPL SET ID:9b73979c-c95a-4433-0a9d-f9cea3cb557f
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1659292
  • 1659294
  • 1659283
  • 1659287
  • Pharmacological Class

    • Cephalosporin Antibacterial [EPC]
    • Cephalosporins [CS]

    NDC Crossover Matching brand name "TAZICEF" or generic name "Ceftazidime"

    NDCBrand NameGeneric Name
    0409-5082TAZICEFCEFTAZIDIME
    0409-5084TAZICEFCEFTAZIDIME
    0409-5086TAZICEFCEFTAZIDIME
    0409-5092TAZICEFCEFTAZIDIME
    0409-5093TAZICEFCEFTAZIDIME
    0781-3177CeftazidimeCeftazidime
    0781-3178CeftazidimeCeftazidime
    0781-3179CeftazidimeCeftazidime
    25021-127Ceftazidimeceftazidime
    0264-3143Ceftazidime and DextroseCEFTAZIDIME
    0264-3145Ceftazidime and DextroseCEFTAZIDIME

    Trademark Results [TAZICEF]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    TAZICEF
    TAZICEF
    77918467 3837729 Live/Registered
    Hospira, Inc.
    2010-01-22
    TAZICEF
    TAZICEF
    74334058 1783825 Dead/Cancelled
    SmithKline Beecham Corporation
    1992-11-23
    TAZICEF
    TAZICEF
    73489701 1412941 Dead/Cancelled
    SMITHKLINE BECKMAN CORPORATION
    1984-07-13

    © 2023 FDA.report
    This site is not affiliated with or endorsed by the FDA.